A REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE

Size: px
Start display at page:

Download "A REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE"

Transcription

1 BYLINED ARTICLE ON: A REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE By Mark Leimbeck PE Underwriters Laboratories and Larry Kessler Sc.D. Chair University of Washington School of Public Health BY NATURE, MANY MEDICAL DEVICES CAN CARRY A SIGNIFICANT AMOUNT OF RISK, ESPECIALLY THOSE USED ON PARTICULARLY ILL PATIENTS OR THOSE DEVICES THAT ARE INTENDED TO BE LIFE SUSTAIN- ING OR LIFE SUPPORTING. THEREFORE, AN UNDERSTANDING OF THE RISKS INHERENT IN THE APPLICATION OF MEDICAL DEVICES, AND RISK MANAGEMENT HAS ALWAYS BEEN A PART OF THE DESIGN, MANUFAC- TURE, AND POST PRODUCTION PROCESSES ASSOCIATED WITH PLACING MEDICAL DEVICES ON THE MARKET. HOWEVER THE FORMAL REQUIRE- MENTS FOR RISK MANAGEMENT AND ENFORCEMENT OF RISK MANAGE- MENT VARY DEPENDING ON WHERE THE DEVICE WILL BE SOLD AND USED. IN THIS ARTICLE, WE REVIEW THE MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT WITH A SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE. FDA Requirements for Market Entry The FDA has had a considerable level of involvement in international standards committees for many years including representation at the working committee level, taking the lead drafting documents on occasion, and sitting as members of governing councils for parent standards organizations. However, it was not until the passage of the 1997 Food and Drug Administration Modernization Act (FDAMA) that Congress sought to explicitly encourage the widespread use of standards in a regulatory context. The FDAMA states, in part: (c)(1)(a) In addition to establishing a performance standard under this section, the Secretary shall, by publication in the Federal Register, recognize all or part of an appropriate standard established by a nationally or internationally recognized standard development organization for which a person may submit a declaration of conformity in order to meet a premarket submission requirement or other requirement under this Act to which such standard is applicable. We note that though the intention of congress was to encourage the use of standards, the program remained a voluntary one on both FDA s side (having the option to recognize certain standards) and the side of the manufacturer (whether to choose to declare conformity to the standard or not). Thus, there are options for manufacturers that allow declaration to conformity to national (U.S.) and to internationally recognized standards in order to provide a smooth path to regulatory approval. For example, a manufacturer may declare conformity to applicable standards as part of an abbreviated 510(k) submission. This allows a substantially shorter submission rather than providing the FDA directly with data supporting the manufacturer s claims of safety and effectiveness for the product when used as intended. The requirements for market entry whether through the 510(k) or PMA regulatory pathway [ DeviceRegulationandGuidance/HowtoMarketYourDevice/default. htm#link_4] derive directly from law and are embodied in regulations found in the Code of Federal Regulations (CFR). The Quality System Requirements (QSR) only uses a single statement to define the FDA s requirements regarding risk management: 01 For more information E:: ULUniversity@us.ul.com T:: (888)

2 Design validation shall include software validation and risk analysis Comment 83 to the 1996 QSR document defines the risk analysis process much more broadly than the term has come to be used in the decade or so since publication of the QSR. The FDA intent in 1996 included identification of possible hazards, determination of the risk acceptability by the manufacturer, and risk mitigation strategies. In addition, in the comments to the 1996 QSR, the FDA notes it transitioned from using the term hazard analysis to the more general term risk analysis to indicate that manufacturers are expected to identify possible hazards associated with the device in both normal and fault conditions. Risks should be calculated in both normal and fault conditions including cases of use error (previously referred to as user error but changed more recently in the field to remove the blame aspect of errors) and actions must be taken to reduce unacceptable errors by acceptable means. According to FDA, an important part of risk analysis is ensuring that changes made to eliminate or minimize hazards do not introduce new hazards. These comments directly mirror Clause 6.6 of ISO (risk control) and for all practical purposes are roughly equivalent. The risk control measures in ISO include risk reduction, residual risk evaluation, and the intention to not introduce new risks into the process. These are similar (though not identical) to the intent of the comments of FDA regarding quality systems. What this means in practical terms is that while the FDA does not by regulation (or law) require the manufacturer s use of all of ISO throughout the design, production, and post production life cycle of the product, the comments of the 1996 QSR and statements by FDA officials in public regarding handling risk management show little distinction between FDA de facto requirements and ISO Perhaps the biggest single difference may lie in the extensive documentation an EU notified body might need to assess conformity to ISO versus what might be absolutely necessary on an FDA QSR inspection. OSHA Requirements The OSHA Instructions per Directive Number CPL 1-03, NRTL Program Policies, Procedures, and Guidelines Appendix C, Sections XII, the requirements state in part: XII. Follow-up Inspection Program. A Nationally Recognized Testing Laboratory (NRTL) must provide inspections of manufacturing facilities, as required under 29 CFR (b)(2). As part of meeting this requirement, an NRTL must meet the criteria in paragraph III of this Appendix, and must: A. Perform initial assessment of the manufacturing facility, manufacturer s quality control system, records and documents, and evaluations and tests required by the Standard, following written procedures. B. Have and adhere to written contracts, agreements or procedures for the client-laboratory relationship that should include: 8. Controls to ensure that all quality management system and production records will be open and readily available for inspection by the laboratory. Placing these requirements in the context of an ISO based declaration of conformity, and recognizing the requirements in Clause 9 of ISO for Production and Post Production Information, there is a clear linkage between these requirements and the establishment of a mechanism to demonstrate ongoing conformity with these requirements for staff performing inspections under the NRTL program. Such information would be quite compatible with FDA requirements for design controls and manufacturing under the QSR (production information), complaint handling and postmarket surveillance (post-production information). European Union Requirements In the EU, the requirements for risk management are somewhat different. Manufacturers must demonstrate conformance with the essential principles of performance for a device to be placed on the market. This contrasts with the FDA s reliance on demonstration of safety and effectiveness (which is either done directly with a PMA product or by a statement of substantial equivalence via the 510(k) process where the predicate device is assumed to have an acceptable level of safety and effectiveness). It may be worth noting that the FDA recently has faced the challenge of what to do with predicate devices and current market applications when the 02 For more information E:: ULUniversity@us.ul.com T:: (888)

3 state of the science has changed over recent years. If a system of essential principles were in place, then as the science changes, these essential principles move with the science. Currently the 510(k) system relies on predicates to provide a baseline level of safety and effectiveness, and handles technology evolution issues by providing narrow indications for market clearance to maintain an adequate safety profile. In contrast, the EU essential principles embody basic elements of device performance and specifically note the management of risks as emphasized by the very first Essential Requirement which states: Essential Requirement 1 The devices must be designed and manufactured in such a way that, when used under the conditions and for the purposes intended, they will not compromise the clinical condition or safety of patients, or the safety and health of users, or, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits of the patient and are compatible with a high level of protection of health and safety. The requirement describes the basic process for conducting a risk benefit analysis (also part of Essential Requirement 6) for devices, noting that a high level of public safety is required. The Essential Requirements continue: Essential Requirement 2 The solutions chosen by the manufacturer for the design and construction of the devices must conform to safety principles, taking into account the generally acknowledged state of the art. In selecting the most appropriate solutions, the manufacturer must apply the following principles in the order indicated: Eliminate or reduce risks as far as possible (inherent safe design) Where appropriate take adequate protective measures Inform users of residual risks (information for safety) This requirement outlines option analysis and risk control, a familiar hierarchy which has its roots in IEC standards. We then turn to the Annexes for implementation approaches: Annexes II (full quality assurance) and III (EC type examination) of the Medical Device Directive both require that a risk analysis be done (similarly for the In Vitro Device Directive). The directives also require procedures to review post-production experience and apply corrective action. Together with the previously noted essential requirements the EU regulatory system has, in principle, defined a risk management process. Thus, for routes to a declaration of conformity that require a notified body, you must demonstrate to the Notified Body that you have implemented risk management. Specifically: Annex VII (EC declaration of conformity) states: The technical documentation must include the results of the risk analysis. The manufacturer shall institute a systematic procedure to review experience gained in the post production phase Manufacturers must attest that they have done this. These requirements together with the essential requirements also define a risk management process. Whatever route to conformity with the essential requirements, a Declaration of Conformity must be signed by the manufacturer, attesting to this fact. So, whether or not a notified body is involved, risk management is necessary. Canada and Australia In contrast to the US FDA discussion, the existence of ISO as a normative reference to commonly used standards, such as , means that ISO is a mandatory requirement, as opposed to informative. Where conformity assessment bodies are used, this will be the requirement with which manufacturers will need to comply. For example, in 2008, the Australian Therapeutic Goods Administration declared that ISO is to be used as an approach to identify risks associated with the device; with the following exception: this standard is not to be used as a specific means to implement the reduction of risks ( au/legis/mdsorm2008.htm) However the balance of the requirements given by the TGA very much aligns with the requirements of ISO Canada has more guidance and encouragement about risk 03 For more information E:: ULUniversity@us.ul.com T:: (888)

4 management: Does the Manufacturer have a quality plan (which is also submitted to Health Canada with Class IV medical device applications) that specifies the processes and resources for specific medical devices? Have risk assessment and control measures been performed throughout the product realization process for all classes of medical devices? Note 1: See ISO 14971:2000 for guidance related to risk management. Note 2: See GHTF SG3 guidance document Risk Management as an Integral Part of the Quality Management System for additional guidance ( How To Prepare a Declaration of Conformity for FDA Using a Recognized Standard In preparing a declaration of conformity to recognized standards, manufacturers should refer to the guidance document, Recognition and Use of Consensus Standards. (see MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm htm) Declarations of conformity to recognized standards should include the following: An identification of the applicable recognized consensus standards that were met; A specification, for each consensus standard, that all requirements were met, except for inapplicable requirements or deviations noted below; An identification, for each consensus standard, of any way(s) in which the standard may have been adapted for submission to the device under review, e.g., an identification of an alternative series of tests that were performed; An identification, for each consensus standard, of any requirements that were not applicable to the device; A specification of any deviations from each applicable standard that were applied (e.g., deviations from international standards which are necessary to meet U.S. infrastructure conventions such as the National Electrical Code (ANSI/NFPA 70); A specification of the differences that may exist, if any, between the tested device and the device to be marketed and a justification of the test results in these areas of difference; and, The name and address of any test laboratory or certification body involved in determining the conformance of the device with the applicable consensus standards and a reference to any accreditations of those organizations. FDA and Compliance Issues Although this would surprise many in the lay audience, FDA does not give a stamp of approval. Rather, the responsibility for product safety and effectiveness rests squarely with the manufacturer with no explicit or implied warranty by the FDA. FDA inspectors are there to check to determine whether the law has been upheld. This includes adequate documentation of the entire life cycle process for each product on the market, and the corresponding assessment via documentation that the manufacturer has complied with FDA regulations, including the quality management system which is most often the central focus of inspections. Thus, an adequate risk management system would be expected by the FDA. As such, the FDA investigators are there on behalf of the consumers of the product. By its vigilance in this role, the FDA believes it heightens patient safety related to devices on the U.S. market. Given this, it is desirable to understand how compliance with ISO would be viewed in the context of an inspection. Along with a functioning and adequately documented quality system, compliance with ISO would almost certainly be more than acceptable for FDA. We note, however, that the standard is currently (and for the foreseeable future) voluntary. If a manufacturer wishes to use an alternative risk management approach, the language of the response to comments of the 1996 QSR makes clear the steps to undertake represent a series of steps that would virtually mirror ISO FDA investigators would likely not accept assertion of compliance with a modern risk management system, such as ISO 14971, without very clear documentation that could later be verified through audit or through some alternative means suggested by the manufacturer with adequate documentation of that alternative approach. 04 For more information E:: ULUniversity@us.ul.com T:: (888)

5 FDA would look to the application of any standard, and in this case, IEC and ISO 14971, and make sure manufacturers are making good decisions, or decisions that are rational, can be explained as part of a consistent decision-making approach, and adequately documented. It is not sufficient (and perhaps not even necessary) to declare conformance to these standards. However, the manufacturer must connect the product lifecycle and its system to ensure that risk control, mitigation, and management decisions are being made in a defensible manner. This would include a system that demonstrated ongoing continuous improvement; this is imbedded in both ISO 9001 and ISO quality system. Because of the dynamic nature of most devices, and with the generally rapid turnover in device generations, it is imperative that the manufacturer have in its files in preparation for audit more than a snapshot in time. As stated earlier, while compliance with ISO is not a FDA requirement, any company would be prudent to document any significant deviations or omissions from ISO or an equivalent risk management process. More than that, the manufacturer must have in place an adequate postmarket surveillance system, and the data from this system connected to evaluation of risks of the product on the market and whether the risks and associated adverse events (AEs) are within the parameters set in the original risk management plan. In addition, this risk management system must also continue to document any foreseeable misuse of the product leading to adverse consequences. Since such off label use is common, but sometimes not well monitored, this can provide a particular challenge for the manufacturer. This entire process sounds straightforward yet it is not for several reasons. Certain types of risk may require the manufacturer to conduct a population estimate of device use and the events associated with that use. Obtaining true estimates of the rates related to device risk is extremely time and resource consuming and challenging. One such study of risks and adverse experience required the hiring of a nurse in a hospital setting merely to observe device use and record AEs (Samore et al.,2004). That approach would not be expected by any regulatory agency. Rather, the expectation of a system for tracking AEs and connection to the risk management plan would include a thorough complaint system and its evaluation. In cases of high risk, specific post market surveillance systems where dedicated data collection is undertaken to measure use and experience with the manufacturer s device would be a means for assuring product safety throughout the lifecycle. Increasingly, the FDA will require specific post market surveillance for high risk products early in the marketing period. To prepare for this, manufacturers may consider designing such studies, and perhaps integrating such data collection plans with the development of product registries that have begun, for example, the implantable cardioverter defibrillator ICD registry of the America Heart Rhythm Society, which as of June 2009, had data from more than 380,000 implants and appears to be growing at a rate of 10,000 implants registered on the registry per month. Feedback loops from postmarket surveillance as part of risk management are the place where companies have historically had problems. Siloing occurs in any bureaucracy and the lack of systematic feedback from those responsible for collecting and evaluating complaints and turning them into Medical Device Reports (MDRs) to the FDA to the product design team or to the compliance team is too common. This can be addressed at the time of product design where the total product life cycle is anticipated and all components of the manufacturer s operation become involved. Summary ISO and Risk management continue to evolve. Regulators around the world have requirements for risk management in place, and if not specifically referencing ISO 14971, certainly mirroring the major elements of this Standard. Given the variety of approaches, a major benefit offered by ISO is the establishment of a consistent set of requirements that formalize a continuous lifecycle approach to risk management. Preparing a declaration of conformity for regulators in different parts of the world may offer challenges on one level, but having a consistent management system in place that is almost universally acknowledged as a benchmark can make the task that much easier. References Samore MH, Evans RS, Lassen A, Gould P, Lloyd J, Gardner RM, Abouzelof R, Taylor C, Woodbury DA, Willy M, Bright RA. Surveillance of medical device-related hazards and adverse events in hospitalized patients. JAMA Jan 21;291(3): For more information E:: ULUniversity@us.ul.com T:: (888) Copyright 2010 Underwriters Laboratories Inc. All right reserved 8/10 BDI

Choices IEC rd Edition and Component Selection

Choices IEC rd Edition and Component Selection Choices IEC 60601-1 3rd Edition and Component Selection Choices IEC 60601-1 3rd Edition and Component Selection Abstract When the 3rd edition of IEC 60601-1 was published, it marked the beginning of a

More information

MEDICAL DEVICE. Technical file.

MEDICAL DEVICE. Technical file. MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing

More information

Current Trends at FDA: Implications for Data Requirements

Current Trends at FDA: Implications for Data Requirements Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable

More information

EA-7/04 Legal Compliance as a part of accredited ISO 14001: 2004 certification

EA-7/04 Legal Compliance as a part of accredited ISO 14001: 2004 certification Publication Reference EA-7/04 Legal Compliance as a part of Accredited ISO 14001: 2004 certification PURPOSE The text of this document has been produced by a working group in the European co-operation

More information

Post market Surveillance ISO EU Medical Device Regulation

Post market Surveillance ISO EU Medical Device Regulation Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes

More information

WHO Prequalification of In Vitro Diagnostics Programme

WHO Prequalification of In Vitro Diagnostics Programme P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s Information for Manufacturers on the Manufacturing Site(s) Inspection (Assessment of the Quality Management System) WHO Prequalification

More information

SADCAS POLICY ISO/IEC 17020:2012 TRANSITION

SADCAS POLICY ISO/IEC 17020:2012 TRANSITION SADCAS POLICY ISO/IEC 17020:2012 TRANSITION Prepared by: SADCAS Approved by: SADCAS CEO Approval Date:2012 09 25 Effective Date: 2012 10 01 Page 1 of 11 Table of Contents Page 1. INTRODUCTION... 3 2. TRANSITION

More information

ISO 9001:2015. October 5 th, Brad Fischer.

ISO 9001:2015. October 5 th, Brad Fischer. ISO 9001:2015 October 5 th, 2017 Brad Fischer www.sdmanufacturing.com Purpose of presentation Provide a summary of notable changes from ISO 9001:2008 to ISO 9001:2015 Key perspectives ISO 9001 needs to

More information

Medical Device Directive

Medical Device Directive Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,

More information

9100 revision Changes presentation clause-by-clause. IAQG 9100 Team November 2016

9100 revision Changes presentation clause-by-clause. IAQG 9100 Team November 2016 Changes presentation clause-by-clause IAQG 9100 Team November 2016 INTRODUCTION In September 2016, a revision of the 9100 standard has been published by the IAQG (International Aerospace Quality Group)

More information

Post Market Surveillance (including PMCF): common non compliances

Post Market Surveillance (including PMCF): common non compliances Post Market Surveillance (including PMCF): common non compliances Jayanth Katta Ph.D Product Specialist & Certification Manager, General Devices Team, Healthcare 1 Overview EU PMS Requirements for Medical

More information

GUIDELINES ON MEDICAL DEVICES CLINICAL EVALUATION: A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES

GUIDELINES ON MEDICAL DEVICES CLINICAL EVALUATION: A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE GENERAL Consumer Goods Cosmetics and Medical Devices MEDDEV. 2.7.1 Rev.3 December 2009 GUIDELINES ON MEDICAL DEVICES CLINICAL EVALUATION: A GUIDE

More information

GENERAL AND ORGANISATIONAL REQUIREMENTS

GENERAL AND ORGANISATIONAL REQUIREMENTS NBOG working document applicable for MDR and IVDR WD 2017-1 Draft list of documents to be submitted in the application for designation as a notified body under Regulation (EU) 2017/745 and Regulation (EU)

More information

International Standards and EU regulation of medical device software an update

International Standards and EU regulation of medical device software an update International Standards and EU regulation of medical device software an update Sherman Eagles Partner, SoftwareCPR seagles@softwarecpr.com 612 865 0107 1 Who am I? 18 years at Medtronic, retired 2008 Last

More information

Ready or Not: The New Medical Device Regulations Are Here!

Ready or Not: The New Medical Device Regulations Are Here! Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional

More information

ISO Environmental management systems Requirements with guidance for use

ISO Environmental management systems Requirements with guidance for use INTERNATIONAL STANDARD Environmental management systems Requirements with guidance for use ISO 14001 Third edition 2015-09-15 Systèmes de management environnemental Exigences et lignes directrices pour

More information

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part

More information

Regulations governing the application of medical accelerators

Regulations governing the application of medical accelerators Regulations governing the application of medical accelerators in 50 minutes. marko.mehle@cosylab.com 2 1.The wonderland of STANDARDS AND REGULATIONS 3 Laws and standards Medical devices (and systems) are

More information

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01 ASQ Tappan Zee Section Medical Devices, New Regulations and Standards 26 th September / V. Fischer / Rev. 01 Agenda Medical Device, General Aspects Examples Quality System(s) New Regulations & Standards

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

SQF 2000 Guidance. Guidance for Food Sector Category 4 Fresh Produce Pack House Operations. 1st Edition

SQF 2000 Guidance. Guidance for Food Sector Category 4 Fresh Produce Pack House Operations. 1st Edition SQF 2000 for Food Sector Category 4 Fresh Produce Pack House Operations 1st Edition SEPTEMBER 2010 Safe Quality Food Institute 2345 Crystal Drive, Suite 800 Arlington, VA 22202 USA 202-220-0635 www.sqfi.com

More information

Post Market Surveillance

Post Market Surveillance Post Market Surveillance December 6 th, 2017 Michael Maier, Medidee Services Slide 1 Agenda Postmarket surveillance Postmarket clinical follow up (PMCF) Incident reporting What changes with MDR Slide 2

More information

ISO /TS 29001:2010 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER

ISO /TS 29001:2010 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER PETROLEUM, PETROCHEMICAL AND NATURAL GAS INDUSTRIES -- SECTOR-SPECIFIC QUALITY MANAGEMENT SYSTEMS -- REQUIREMENTS FOR PRODUCT AND SERVICE SUPPLY ORGANIZATIONS

More information

AEROSPACE STANDARD. Quality Systems - Aerospace - Model for Quality Assurance in Design, Development, Production, Installation and Servicing

AEROSPACE STANDARD. Quality Systems - Aerospace - Model for Quality Assurance in Design, Development, Production, Installation and Servicing AEROSPACE STANDARD AS9100 Technically equivalent to AECMA pren 9100 Issued 1999-11 Revised 2001-08 Superseding AS9100 REV. A Quality Systems - Aerospace - Model for Quality Assurance in Design, Development,

More information

Guidance on Independent Assessment. Rail Industry Guidance Note. Published by: RSSB Block 2 Angel Square 1 Torrens Street London EC1V 1NY

Guidance on Independent Assessment. Rail Industry Guidance Note. Published by: RSSB Block 2 Angel Square 1 Torrens Street London EC1V 1NY GN Published by: Block 2 Angel Square 1 Torrens Street London EC1V 1NY Copyright 2014 Rail Safety and Standards Board Limited GE/GN8645 Issue One: June 2014 Rail Industry Guidance Note Issue record Issue

More information

Table of Contents. Role of Standards in the Assessment of Medical Devices Study Group 1 Final Document GHTF/SG1/N044:2008

Table of Contents. Role of Standards in the Assessment of Medical Devices Study Group 1 Final Document GHTF/SG1/N044:2008 Table of Contents 1.0 Introduction...4 2.0 Rationale, Purpose and Scope...5 2.1 Rationale...5 2.2 Purpose...5 2.3 Scope...5 3.0 References...5 4.0 Definitions...6 5.0 General Principles...7 5.1 Recognition

More information

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case 701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers

More information

SANAS Transition Policy: ISO/IEC 17020: 2012

SANAS Transition Policy: ISO/IEC 17020: 2012 SANAS Transition Policy: ISO/IEC 17020: 2012 CONTENTS 1 Introduction 2 Transition to ISO/IEC 17020 3 Specific changes in requirements Appendix A: Summary of changes Appendix B: Cross References: ISO/IEC

More information

Korean Medical Devices Regulations

Korean Medical Devices Regulations Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,

More information

ISO/PC Occupational health and safety management systems Requirements with guidance for use

ISO/PC Occupational health and safety management systems Requirements with guidance for use DRAFT INTERNATIONAL STANDARD ISO/DIS 45001.2 ISO/PC 283 Secretariat: BSI Voting begins on: Voting terminates on: 2017-05-19 2017-07-13 Occupational health and safety management systems Requirements with

More information

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries SQF 2000 Code A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries 6th Edition AUGUST 2008 Safe Quality Food Institute 2345 Crystal Drive, Suite 800 Arlington, VA

More information

The Risk Management + Design Controls Connection: What Device Makers Need to Know

The Risk Management + Design Controls Connection: What Device Makers Need to Know !!! The Risk Management + Design Controls Connection: What Device Makers Need to Know Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Intended Use & User Needs 6 Verification, Validation,

More information

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation

More information

Expert Commentary on BS EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes

Expert Commentary on BS EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes Expert Commentary on BS EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes Author: Eamonn Hoxey, PhD, F.R.Pharm.S., Vice President, Medical Devices Quality

More information

In the huge expanse of Asia, Singapore and

In the huge expanse of Asia, Singapore and New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets

More information

White Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014

White Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014 White Paper: Improvements to the Australian Regulatory System for Medical Devices 23 May 2014 mtaa.org.au Medical technology for a healthier Australia 0 www.mtaa.org.au Level 12, 54 Miller St, North Sydney

More information

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,

More information

Comparison Matrix ISO 9001:2015 vs ISO 9001:2008

Comparison Matrix ISO 9001:2015 vs ISO 9001:2008 Comparison Matrix ISO 9001:2015 vs ISO 9001:2008 Description: This document is provided by American System Registrar. It shows relevant clauses, side-by-side, of ISO 9001:2008 standard and the ISO 9001:2015

More information

MALAYSIAN STANDARD QUALITY MANAGEMENT SYSTEMS - REQUIREMENTS (FIRST REVISION) (ISO 9001:2008, IDT) (PUBLISHED BY STANDARDS MALAYSIA IN 2009)

MALAYSIAN STANDARD QUALITY MANAGEMENT SYSTEMS - REQUIREMENTS (FIRST REVISION) (ISO 9001:2008, IDT) (PUBLISHED BY STANDARDS MALAYSIA IN 2009) MALAYSIAN STANDARD MS ISO 9001:2008 QUALITY MANAGEMENT SYSTEMS - REQUIREMENTS (FIRST REVISION) (ISO 9001:2008, IDT) (PUBLISHED BY STANDARDS MALAYSIA IN 2009) ICS: 03.120.10 Descriptors: quality management,

More information

POSITION PAPER Moving from the MDD to the MDR

POSITION PAPER Moving from the MDD to the MDR A summary of Key Changes regarding Sterile Packaging and considerations on recommended changes to standards Introduction EN ISO 11607 specifies the requirements and test methods for materials, preformed

More information

Moving from ISO/TS 16949:2009 to IATF 16949:2016. Transition Guide

Moving from ISO/TS 16949:2009 to IATF 16949:2016. Transition Guide Moving from ISO/TS 16949:2009 to IATF 16949:2016 Transition Guide IATF 16949:2016 - Automotive Quality Management System - Transition Guide An effective Quality Management System is vital for organizations

More information

AUSTRALIAN MEDICAL DEVICES GUIDANCE DOCUMENT NUMBER 5. The Declaration of Conformity

AUSTRALIAN MEDICAL DEVICES GUIDANCE DOCUMENT NUMBER 5. The Declaration of Conformity AUSTRALIAN MEDICAL DEVICES GUIDANCE DOCUMENT NUMBER 5 The Declaration of Conformity 30 October 2003 DISCLAIMER This document is provided for guidance only. It should not be relied upon to address every

More information

FDA Initiatives and Regulatory Trends for Life Sciences. Larry Spears President L. Spears Consulting

FDA Initiatives and Regulatory Trends for Life Sciences. Larry Spears President L. Spears Consulting FDA Initiatives and Regulatory Trends for Life Sciences Larry Spears President L. Spears Consulting Before We Begin If you experience technical problems, please contact GoToMeeting Technical Support at

More information

Overview of the U.S. Standardization System

Overview of the U.S. Standardization System A publication of the American National Standards Institute Overview of the U.S. Standardization System Voluntary Consensus Standards and Conformity Assessment Activities Second edition: July 2007 American

More information

April 2017 Latest update. ISO/DIS Understanding the new international standard for occupational health & safety

April 2017 Latest update. ISO/DIS Understanding the new international standard for occupational health & safety April 2017 Latest update ISO/DIS 45001.2 Understanding the new international standard for occupational health & safety ISO/DIS 45001.2 - Understanding the new international standard for occupational health

More information

AS/NZS 4804:2001. Occupational health and safety management systems. General guidelines on principles, systems and supporting techniques

AS/NZS 4804:2001. Occupational health and safety management systems. General guidelines on principles, systems and supporting techniques Australian/New Zealand Standard Occupational health and safety management systems General guidelines on principles, systems and supporting techniques This Joint Australian/New Zealand Standard was prepared

More information

TABLE OF CONTENTS 1.0 INTRODUCTION...

TABLE OF CONTENTS 1.0 INTRODUCTION... Advisory Circular Subject: Quality Assurance Programs Issuing Office: Civil Aviation, Standards Document No.: AC QUA-001 File Classification No.: Z 5000-34 Issue No.: 01 RDIMS No.: 9376810-V14 Effective

More information

Combination Products Part 4 Compliance and Implementation at multi-site Network

Combination Products Part 4 Compliance and Implementation at multi-site Network Combination Products Part 4 Compliance and Implementation at multi-site Network Vijay Damodaran Eli Lilly & Company September 27, 2017 Contents Key cgmp requirements for combination products How to perform

More information

HP Standard Supplier Requirements for Safe and Legal Products

HP Standard Supplier Requirements for Safe and Legal Products HP Standard 014-2 Supplier Requirements for Safe and Legal Products Document Identifier Revision and Date Last Revalidation Date Abstract Applicability Status HX-00014-02 G, This standard describes HP

More information

Due diligence in the European medical devices industry

Due diligence in the European medical devices industry Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's

More information

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007

More information

INTERNATIONAL STANDARD

INTERNATIONAL STANDARD INTERNATIONAL STANDARD ISO 9001 Quality management systems Requirements Systèmes de management de la qualité Exigences Fourth edition 2008-11-15 Reference number ISO 9001:2008(E) ISO 2008 PDF disclaimer

More information

GE/GN8640. Risk Evaluation and Assessment. Guidance on Planning an Application of the Common Safety Method on. Rail Industry Guidance Note

GE/GN8640. Risk Evaluation and Assessment. Guidance on Planning an Application of the Common Safety Method on. Rail Industry Guidance Note GN Published by: Block 2 Angel Square 1 Torrens Street London EC1V 1NY Copyright 2014 Rail Safety and Standards Board Limited GE/GN8640 Method on Risk Evaluation and Assessment Issue One; June 2014 Rail

More information

ISO 9001:2015 Readiness Review

ISO 9001:2015 Readiness Review ISO 9001:2015 Readiness Review Company Name Address Certification No. Contact Name Job Title Telephone Email BSI is committed to ensuring a smooth assessment for all clients wishing to certify to ISO 9001:2015,

More information

FINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports

FINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair

More information

Guidance on the Application. of ISO / IEC Accreditation International Association for Certifying Bodies

Guidance on the Application. of ISO / IEC Accreditation International Association for Certifying Bodies Accreditation International Association for Certifying Bodies Guidance on the Application of ISO / IEC 17020 Guidance on the Application of ISO/IEC 17020 Page 1 of 16 Introduction This guidance document

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994

Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 SUR-G0006-2 27 AUGUST 2010 This guide does not purport to be an interpretation of law and/or

More information

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011 Draft Guidance for Industry and Food and Drug Administration Staff The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] DRAFT GUIDANCE This guidance document is being

More information

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Regulatory and Compliance Counsel, BioTeknica Panelists:

More information

When Recognition Matters WHITEPAPER ISO 14001:2015 ENVIRONMENTAL MANAGEMENT SYSTEMS - REQUIREMENTS.

When Recognition Matters WHITEPAPER ISO 14001:2015 ENVIRONMENTAL MANAGEMENT SYSTEMS - REQUIREMENTS. When Recognition Matters WHITEPAPER ISO 14001:2015 ENVIRONMENTAL MANAGEMENT SYSTEMS - REQUIREMENTS www.pecb.com CONTENT 3 4 5 8 8 9 10 11 12 Introduction An overview of ISO 14001:2015 Key clauses of ISO

More information

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited. Statutory Framework for Devices Medical Devices Investigational Use Application IDE (21 CFR 812) Abbreviated IDE Exempt Pre-Market Approval Applications 510(k) Pre-marketing Notification (21 CFR 807(e))

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

5 Countries. 1 Unified Audit.

5 Countries. 1 Unified Audit. 5 Countries. 1 Unified Audit. UNDERSTANDING THE MEDICAL DEVICE SINGLE AUDIT PROGRAM (MDSAP) Melodie Kahl, Mike Wolf, and Scott Edwards July 2017 For more information, please contact: USA Office: + 1 877

More information

The In Vitro Diagnostic CRO

The In Vitro Diagnostic CRO The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro

More information

Getting Started with ISO in Your Lab: Introduction to Resources, Training, Implementation, and Timelines for Earning Accreditation

Getting Started with ISO in Your Lab: Introduction to Resources, Training, Implementation, and Timelines for Earning Accreditation Getting Started with ISO 15189 in Your Lab: Introduction to Resources, Training, Implementation, and Timelines for Earning Accreditation Topics What is ISO 15189? What is Accreditation? Preparing for Assessment

More information

GUIDELINES ON MEDICAL DEVICES

GUIDELINES ON MEDICAL DEVICES EUROPEAN COMMISSION DIRECTORATE GENERAL for HEALTH and CONSUMERS Consumer Affairs Cosmetics and Medical Devices MEDDEV 2.7/4 December 2010 GUIDELINES ON MEDICAL DEVICES GUIDELINES ON CLINICAL INVESTIGATION:

More information

Application of ISO/IEC 17011:2004 in the Field of Medical Device Quality Management Systems (ISO 13485)

Application of ISO/IEC 17011:2004 in the Field of Medical Device Quality Management Systems (ISO 13485) IAF Mandatory Document Application of ISO/IEC 17011:2004 in the Field of Medical Device Quality Management Systems (ISO 13485) Issue 3 (IAF MD 8:2017) Issued: 09 June 2017 Application Date: 09 June 2018

More information

Draft Guidance for Industry Development and Use of Risk Minimization Action Plans

Draft Guidance for Industry Development and Use of Risk Minimization Action Plans Draft Guidance for Industry Development and Use of Risk Minimization Action Plans Docket Number [2004D-0188] Submitted to the U.S. Department of Health and Human Services Food and Drug Administration Center

More information

CUSTOMER RELATIONSHIPS FURTHER EXCELLENCE GENERIC STANDARDS TRAINING SERVICES THE ROUTE TO ISO 9001:2015 AVOIDING THE PITFALLS

CUSTOMER RELATIONSHIPS FURTHER EXCELLENCE GENERIC STANDARDS TRAINING SERVICES THE ROUTE TO ISO 9001:2015 AVOIDING THE PITFALLS PROCESSES SUPPLY CHAIN SKILLED TALENT CUSTOMER RELATIONSHIPS FURTHER EXCELLENCE GENERIC STANDARDS INDUSTRY STANDARDS CUSTOMISED SOLUTIONS TRAINING SERVICES THE ROUTE TO ISO 9001:2015 FOREWORD The purpose

More information

ISO/DIS 9001: 2014 comparison with ISO 9001:2008. ISO 9001:2015 Updates. (Based on Draft International Standard, DIS) ISO/DIS 9001 ISO 9001:2008

ISO/DIS 9001: 2014 comparison with ISO 9001:2008. ISO 9001:2015 Updates. (Based on Draft International Standard, DIS) ISO/DIS 9001 ISO 9001:2008 ISO 9001:2015 Updates (Based ondraft International Standard, DIS) August 2014 Page 1 ISO 9001:2015 Updates (Based on Draft International Standard, DIS) ISO/DIS 9001: 2014 comparison with ISO 9001:2008

More information

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs An Introduction to the Worldwide Regulatory Framework for Medical Devices Elizabeth Malo M.S., Director, Regulatory Affairs Course Outline / Agenda» Overview Device Regulatory Framework» US/EU/Canada Premarket

More information

EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services

EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services The importance of accreditation of conformity assessment bodies has substantially increased over the last decades.

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 11 Status : APPROVED Effective: 09/07/2017 Page 2 of 32 Quality Manual Table of Contents

More information

Moving from ISO 14001:2004 to ISO 14001:2015 Transition Guide

Moving from ISO 14001:2004 to ISO 14001:2015 Transition Guide ISO Revisions Final Standard Moving from ISO 14001:2004 to ISO 14001:2015 Transition Guide ISO 14001 - Environmental Management System - Transition Guide Successful businesses understand that it is the

More information

Process validation in medical devices

Process validation in medical devices Process validation in medical devices Fulfil requirements with expert regulatory guidance 1TÜV SÜD Contents INTRODUCTION 4 VALIDATION PLANNING 5 INSTALLATION QUALIFICATION 7 OPERATIONAL QUALIFICATION 9

More information

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES MDEG - 2007-12 - II-3.3 MSOGClassIGuidance_Final GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES Foreword These guidance notes do not aim to be a definite interpretation of National Laws and/or

More information

Principles of the Railway Industry Supplier Qualification Scheme

Principles of the Railway Industry Supplier Qualification Scheme RISQS/001 Issue 1.2 Date: December 2015 Principles of the Railway Industry Supplier Qualification Scheme Copyright 2013 Rail Safety and Standards Board Limited. This document is subject to copyright protection.

More information

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite A white paper discussing the compliant use of the Oracle Electronic Record, Electronic Signature (E-Records)

More information

Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations

Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Paul Brooks Vice President Healthcare, Americas Presentation to:

More information

IECQ PUBLICATION QC IEC Quality Assessment System for Electronic Components (IECQ System)

IECQ PUBLICATION QC IEC Quality Assessment System for Electronic Components (IECQ System) QC 080000 Edition 3.0 2012-05 IECQ PUBLICATION IEC Quality Assessment System for Electronic Components (IECQ System) Hazardous Substance Process Management System Requirements (HSPM) QC 080000:2012(E)

More information

Moving to the AS9100:2016 series. Transition Guide

Moving to the AS9100:2016 series. Transition Guide Moving to the AS9100:2016 series Transition Guide AS9100-series - Quality Management Systems for Aviation, Space and Defense - Transition Guide Successful aviation, space and defense businesses understand

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

FSC36 SAFE FEED/SAFE FOOD GUIDANCE DOCUMENT

FSC36 SAFE FEED/SAFE FOOD GUIDANCE DOCUMENT FSC36 SAFE FEED/SAFE FOOD GUIDANCE DOCUMENT FSC36 Safe Feed/Safe Food (www.safefeedsafefood.org) is a facility certification program for the American Feed Industry Association (www.afia.org) Version 7.0

More information

ISO/TS TECHNICAL SPECIFICATION

ISO/TS TECHNICAL SPECIFICATION TECHNICAL SPECIFICATION ISO/TS 29001 Third edition 2010-06-01 Petroleum, petrochemical and natural gas industries Sector-specific quality management systems Requirements for product and service supply

More information

ELECTROTECHNIQUE IEC INTERNATIONALE INTERNATIONAL ELECTROTECHNICAL

ELECTROTECHNIQUE IEC INTERNATIONALE INTERNATIONAL ELECTROTECHNICAL 61508-1 IEC: 1997 1 Version 4.0 05/12/97 COMMISSION CEI ELECTROTECHNIQUE IEC INTERNATIONALE 61508-1 INTERNATIONAL ELECTROTECHNICAL COMMISSION Functional safety of electrical/electronic/ programmable electronic

More information

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES Agnette de Perio Peralta and Maria Cecilia Credo Matienzo (apperalta@co.doh.gov.ph and mccmatienzo@yahoo.com) Center for Device

More information

ASSURANCE FRAMEWORK. A framework to assure the Board that it is delivering the best possible service for its citizens SEPTEMBER 2010.

ASSURANCE FRAMEWORK. A framework to assure the Board that it is delivering the best possible service for its citizens SEPTEMBER 2010. ASSURANCE FRAMEWORK A framework to assure the Board that it is delivering the best possible service for its citizens SEPTEMBER 2010 V3 Draft 1 SECTION NO. ASSURANCE FRAMEWORK CONTENTS 1. INTRODUCTION 3

More information

APEC Occupational Standards Framework. Draft 1.2

APEC Occupational Standards Framework. Draft 1.2 APEC Occupational Standards Framework Draft 1.2 January 2016 Table of Contents List of acronyms... 3 Background... 4 Chronological development... 4 Structure... 5 Scope... 5 Purpose... 5 Principles...

More information

INFORMATION GOVERNANCE STRATEGY. Documentation control

INFORMATION GOVERNANCE STRATEGY. Documentation control INFORMATION GOVERNANCE STRATEGY Documentation control Reference Date Approved Approving Body Version Supersedes Consultation Undertaken Target Audience Supporting procedures GG/INF/01 TRUST BOARD Information

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

Quick Guide: Field Labelling, Limited Product Certifications and Special Inspections for USA & Canada

Quick Guide: Field Labelling, Limited Product Certifications and Special Inspections for USA & Canada Quick Guide: Field Labelling, Limited Product Certifications and Special Inspections for USA & Canada Intertek Cleeve Road, Leatherhead, Surrey KT22 7SB UK info.uk@intertek.com 01372 370900 www.intertek.com

More information

MEMORANDUM TO COMMUNITIES AND LOCAL GOVERNMENT SELECT COMMITTEE ON PART P OF BUILDING REGULATIONS

MEMORANDUM TO COMMUNITIES AND LOCAL GOVERNMENT SELECT COMMITTEE ON PART P OF BUILDING REGULATIONS MEMORANDUM TO COMMUNITIES AND LOCAL GOVERNMENT SELECT COMMITTEE ON PART P OF BUILDING REGULATIONS Introduction 1. In April 2013 we amended Part P of the Building Regulations to: reduce the amount of minor

More information

Proposed Changes to Certain Provisions of the Code Addressing the Long Association of Personnel with an Audit or Assurance Client

Proposed Changes to Certain Provisions of the Code Addressing the Long Association of Personnel with an Audit or Assurance Client IFAC Board Exposure Draft August 2014 Comments due: November 12, 2014 Exposure Draft October 2011 Comments due: February 29, 2012 International Ethics Standards Board for Accountants Proposed Changes to

More information

INTERNATIONAL STANDARD

INTERNATIONAL STANDARD INTERNATIONAL STANDARD ISO 19011 Second edition 2011-11-15 Guidelines for auditing management systems Lignes directrices pour l audit des systèmes de management Reference number ISO 19011:2011(E) ISO 2011

More information

Document: ISO/TC 176/SC 2/N 1147

Document: ISO/TC 176/SC 2/N 1147 ISO 2013 All rights reserved Document: ISO/TC 176/SC 2/N 1147 Secretariat of ISO/TC 176/SC 2 Date: 3 June 2013 To the Members of ISO/TC 176/SC 2 - Quality Management and Quality Assurance/ Quality Systems

More information

Recast Medical Device directives Impacts on materiovigilance

Recast Medical Device directives Impacts on materiovigilance Recast Medical Device directives Impacts on materiovigilance Journée Vigilance 23.03.2017 Valérie Nys Revision of the EU Medical Devices Legislation Directive 90/385/EEC on active implantable medical devices

More information

ASSESSING NSQF QUALIFICATIONS. Assessors Handbook

ASSESSING NSQF QUALIFICATIONS. Assessors Handbook ASSESSING NSQF QUALIFICATIONS Assessors Handbook 1 High-Quality Assessment in NSQF Qualifications Effective, consistent and quality-assured assessment is essential for qualifications. It enables the qualifications

More information

TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY

TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY SAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY D7-24 5-2004 FOREWORD This Part of SASO s Technical Directives is Adopted

More information

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005 WWW.SYSTEMKARAN.ORG 1 www.systemkaran.org Foreword... 6 Introduction... 7 Food safety management systems Requirements

More information